Controversial Painkiller Raises Alarm After British Expat’s Mysterious Death in Spain

Controversial Painkiller Raises Alarm After British Expat’s Mysterious Death in Spain

British Expats in Spain Exposed to Over-the-Counter Painkiller Linked to Dozens of Deaths

Outrage has erupted over the availability of the painkiller metamizole, banned in Britain for decades, in Spain.

Campaigners express concerns that the drug, obtainable over-the-counter for as little as €4, is linked to the deaths of British expats.

The controversy gained prominence following the recent death of Mark Brooks, with claims suggesting a potential connection to the painkiller.

Hidden Dangers of Metamizole

Metamizole, banned in the UK since the 60s-70s due to safety concerns, remains a common painkiller in countries like Spain.

Despite being theoretically prescription-only, reports indicate that enforcement is lacking.

The drug, sold under the brand name Nolotil, has been linked to an alarming number of fatalities, including British expats Gloria and Alan Robson and Lorna Vincent.

Unenforced Regulations and Concerns

While Spanish medics were advised to avoid prescribing Nolotil to British tourists in 2018, reports suggest lax enforcement.

An unpublished study indicated an increased risk of agranulocytosis in Brits compared to Spanish patients, yet a comprehensive scientific analysis is still pending.

Campaign groups like the Association for Drug Affected People (ADAF) call for heightened awareness, citing potential negligence.

Criminal Complaints and Human Rights Concerns

ADAF’s president, Cristina Garcia del Campo, has filed a criminal complaint, accusing officials of negligence.

The complaint questions why a drug banned in various countries is readily available in Spain, putting tourists at risk.

Del Campo emphasizes the urgent need for a thorough investigation and asserts the issue as a matter of human rights.

International Ramifications

The dangers of metamizole extend beyond Spain, as the painkiller is available in other European holiday destinations and developing nations.

With 40 countries, including the US, Canada, and Australia, banning the drug, concerns about its safety persist.

The manufacturer, Boehringer Ingelheim, insists on cooperation with regulators and maintains that current prescribing information addresses identified risks.

Campaigner’s Determination

Cristina Garcia del Campo vows to persist in her fight against the potentially lethal effects of Nolotil.

She challenges the negligence of officials and calls for immediate action to prevent further casualties.

The controversy underscores the need for heightened awareness among British tourists and raises questions about the safety of widely available drugs in popular holiday destinations.

TDPel Media

This article was published on TDPel Media. Thanks for reading!

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn

Advertisement: Download Vital Signs App (VS App)